Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Eur J Pharmacol ; 341(2-3): 257-63, 1998 Jan 12.
Article in English | MEDLINE | ID: mdl-9543247

ABSTRACT

We investigated the effects of the continuous infusion of various steroids in rats on renal tubular reabsorption of glucose in vivo to elucidate the pathogenesis of steroid-induced glucosuria. Urinary glucose excretion increased 60 min after administration of dexamethasone (2.38 mM). By 120 min, urinary excretion of glucose was three times higher in the dexamethasone group than in the control group (24.1 +/- 4.6 versus 72.4 +/- 16.7 micromol); the plasma level of glucose did not increase. Dexamethasone had no effect on the resorption of 1,5-anhydro-D-glucitol, which is a glucose-resembling polyol that is actively absorbed by the renal tubules as glucose. Neither estradiol nor progesterone increased urinary excretion of glucose. These findings suggest that continuous administration of a high-dose glucocorticoid selectively influences the glucose reabsorption system in the kidney.


Subject(s)
Blood Glucose/drug effects , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Glycosuria/chemically induced , Animals , Deoxyglucose/metabolism , Dexamethasone/administration & dosage , Dexamethasone/adverse effects , Dose-Response Relationship, Drug , Estradiol/pharmacology , Glucocorticoids/administration & dosage , Glucocorticoids/adverse effects , Glycosuria/metabolism , Infusions, Intravenous , Insulin/blood , Male , Progesterone/pharmacology , Rats , Rats, Wistar
2.
Diabetes Care ; 21(4): 619-24, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9571353

ABSTRACT

OBJECTIVE: This prospective study was designed to elucidate the relationship between the serum level of 1,5-anhydroglucitol (1,5AG) and the urinary excretion of N-acetylglucosaminidase (NAG) and albumin in patients who were in the early stages of diabetes. RESEARCH DESIGN AND METHODS: A total of 1,062 male nondiabetic subjects with impaired glucose tolerance were monitored for blood glucose level once every 2-3 months, and the values were evaluated. Of these 1,062 subjects, 112 showed a worsening of glycemia during the observation period to the level seen in diabetes. We began to monitor the glycemia and parameters of renal damage in the 112 patients from the onset of diabetes. RESULTS: The urinary excretion of NAG and albumin were elevated even at the onset of diabetes. The abnormal excretion of NAG and albumin was associated with a change in serum 1,5AG and was quickly reversible when the serum 1,5AG improved. In the 3 years after the onset of diabetes, we obtained at least 18 measurements of one parameter for each patient and calculated the mean. Urinary NAG was found to be significantly correlated with the fasting plasma level of glucose (FPG; r = 0.512, P < 0.0001), the level of HbA1 (r = 0.351, P = 0.001), and the level of 1,5AG (r = -0.790, P < 0.0001). The urinary excretion of albumin was weakly but significantly correlated with levels of FPG (r = 0.383, P < 0.0001) and HbA1 (r = 0.337, P < 0.0001), but it was more strongly correlated with 1,5AG (r = -0.632, P < 0.0001). The level of 1,5AG was significantly correlated with FPG (r = -0.681, P < 0.0001) and HbA1 (r = -0.609, P < 0.0001). CONCLUSIONS: When the renal damage is not severe, the serum level of 1,5AG appeared to be an indicator of the reversible renal damage caused by hyperglycemia, as well as of the severity of the glycemia itself.


Subject(s)
Acetylglucosaminidase/blood , Albuminuria , Deoxyglucose/blood , Diabetes Mellitus, Type 2/blood , Glucose Intolerance/blood , Adult , Albuminuria/epidemiology , Biomarkers/blood , Biomarkers/urine , Blood Glucose/analysis , Blood Pressure , Blood Proteins/analysis , Cholesterol/blood , Cholesterol, HDL/blood , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/urine , Diabetic Neuropathies/blood , Diabetic Neuropathies/urine , Follow-Up Studies , Glucose Intolerance/physiopathology , Glucose Intolerance/urine , Glucose Tolerance Test , Humans , Hypoglycemic Agents/therapeutic use , Isomerism , Male , Middle Aged , Prospective Studies , Regression Analysis , Sulfonylurea Compounds/therapeutic use , Time Factors , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL